Accredited Partner Hospital Network in China
Direct access to China's foremost National Medical Centers, National Cancer Centers, and university-affiliated tertiary teaching hospitals. We strictly adhere to 100% public tertiary (Tier-3A) hospital resources, connecting international patients with multidisciplinary tumor boards, expedited VIP inpatient beds, and premier clinical specialists across Shanghai, Beijing, and Guangzhou.
Huashan Hospital, Fudan University
- World-renowned Neurosurgery & Brain Tumor MDT Center
- Intraoperative 3.0T MRI navigation & awake craniotomy
- Dedicated International Medical Center (15 min from Hongqiao Hub)
Shanghai Proton & Heavy Ion Center (SPHIC)
- Dual proton & carbon ion synchrotron beam accelerators
- Sub-millimeter Bragg peak targeted tumor destruction
- Ultra-low collateral toxicity for chordomas, CNS & skull base tumors
Ruijin Hospital, SJTU School of Medicine
- Premier hematology research institute & CAR-T clinical trials
- High-volume autologous & allogeneic bone marrow transplantation
- Robotic-assisted pancreatic, gastrointestinal & minimally invasive surgery
Fudan University Shanghai Cancer Center
- China's top comprehensive oncology specialty institution
- Breast, lung, gastrointestinal & gynecological cancer MDT boards
- Leading site for international phase I-III precision oncology drug trials
Renji Hospital, SJTU School of Medicine
- World-leading liver transplantation volume & hepatoma resection
- Da Vinci robotic surgery for renal, bladder & prostate cancers
- State clinical research center for digestive & autoimmune disorders
Seventh People's Hospital of Shanghai (SHUTCM)
- Evidence-based integrative Chinese & Western oncology care
- Targeted toxicity mitigation during chemo & radiation therapy
- Post-treatment immune recovery & specialized palliative management
Cancer Hospital, Chinese Academy of Medical Sciences
- China's premier national authority for oncology clinical practice
- World-leading thoracic & esophageal cancer surgical resection volume
- Headquarters for national standard-of-care guidelines and drug registries
Peking University Cancer Hospital
- Global benchmark in gastric & colorectal cancer neoadjuvant MDT
- Pioneering melanoma, sarcoma & rare solid tumor immunotherapy trials
- Minimally invasive interventional oncology & local ablation programs
Chinese PLA General Hospital (301 Hospital)
- Highest-tier comprehensive clinical hospital in Northern China
- National center of excellence for robotic-assisted oncological surgery
- Advanced multi-organ critical care & complex multidisciplinary salvage
Sun Yat-sen University Cancer Center (SYSUCC)
- World's highest cure and survival rates for nasopharyngeal carcinoma (NPC)
- Top-ranked liver, colorectal & thoracic surgical oncology volume
- South China's leading comprehensive cancer prevention & clinical trials hub
Guangdong Provincial People's Hospital (GDPH)
- International pioneer in molecular targeted therapy for lung cancer
- World-leading clinical trials for 3rd/4th generation EGFR-TKI resistance
- Advanced video-assisted thoracic surgery (VATS) & immunotherapy protocols
HOSPITAL ADMISSION PRE-ASSESSMENT
Request an Expedited Partner Hospital Admission
Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential partner hospital admission pathways in China and assist you in gathering the specific medical records needed for expert hospital review.
HOSPITAL NETWORK FAQS
Frequently Asked Questions About China's Hospitals
Key institutional guidelines on public tertiary hospital access, expedited admissions, language navigation, and medical visas.
China’s Tier-3A academic centers manage the highest surgical and interventional case volumes in the world. Leading centers like Huashan Hospital (neurosurgery) and SPHIC (particle radiation) feature cutting-edge technologies—such as intraoperative 3.0T MRI, dual carbon ion gantries, and commercial CAR-T cell manufacturing—with significantly shorter waiting times than Western centers and transparent healthcare costs typically 30% to 50% of North American or European equivalents.
Public tertiary hospital beds in China are in extremely high demand. Pathway operates through formal institutional agreements and dedicated International Medical Center wings. We submit pre-screened medical dossiers directly to department directors, ensuring guaranteed VIP inpatient reservations and scheduled surgical operating theater slots prior to patient arrival.
Every patient is assigned a certified medical navigator who is fluent in both English and Mandarin. Your navigator attends all bedside rounds, surgical briefings, and nursing sessions. In addition, all diagnostic reports, pathology slides, and discharge summaries are certified and delivered in English for continuity with your home physicians.
We require: (1) Recent clinical summary and diagnostic history; (2) Pathology biopsy and immunohistochemistry (IHC) reports; (3) Digital radiology imaging in DICOM format (CT, MRI, or PET-CT performed within the last 3 months); and (4) Biomarker or NGS genomic sequencing data if available.
The international wings of our partner hospitals (such as Huashan International and SPHIC) work with major global insurers (including Cigna Global, Bupa International, Allianz Worldwide Care, and MSH). Direct billing is supported for pre-approved hospital inpatient treatments, or detailed bilingual super-bills are provided for post-care reimbursement.
International medical VIP departments provide private inpatient suites accommodating a caregiver. For extended outpatient radiotherapy or recovery, accredited international patient hotels and serviced residences within 5 to 10 minutes of hospital campuses are coordinated by our logistics liaisons.